Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01878032 · ClinicalTrials.gov registry record
Color Vision as a Measure for Inherited Retinal Diseases
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 166
- Enrollment target
NCT01878032 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 166 participants.
The verdict
NCT01878032 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 166 participants
- Enrollment target
Study Summary
Background: \- The purpose of this study is to find out whether color vision measured with the Cambridge Color Test is a good way to examine the severity of inherited retinal diseases (IRDs). IRDs are a major cause of vision loss worldwide, but very little is known about how the diseases affect color vision over time. This study will tell us if color vision may be used to track changes in inherited retinal diseases over time. Objectives: \- To improve understanding of color vision as a way to measure changes in inherited retinal diseases. Eligibility: * People 5 years of age or older who have an IRD. * Healthy volunteers at least 5 years of age. Design: * Participants will make at least one visit to the National Eye Institute clinic. If they sign up for more tests, they may have up to three visits to the NEI clinic. * Participants will be asked questions about their medical and eye history. * Participants will be given an eye exam, including eye drops to dilate their pupils. They will take the Cambridge Color Test, which includes looking at a monitor and pressing a button, and arranging colored circles. Several other tests may be offered, but participants can decline to take them. * Treatment will not be provided as part of this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2013-06-03 |
| Est. Completion | 2017-04-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01878032
The ClinicalTrials.gov registry entry for NCT01878032 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01878032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01878032 about?
NCT01878032 is a clinical study titled "Color Vision as a Measure for Inherited Retinal Diseases". Background: \- The purpose of this study is to find out whether color vision measured with the Cambridge Color Test is a good way to examine the severity of inherited retinal diseases (IRDs). IRDs are a major cause of vision loss worldwide, but very little is known about how the diseases affect col...
What is the current status of trial NCT01878032?
This trial is currently completed. The enrollment target is 166 participants. The study started on 2013-06-03. Estimated completion is 2017-04-14.
Who is sponsoring clinical trial NCT01878032?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.